A ‘sponge on a string’ pill test has been hailed a ‘game-changer’ by Cambridge cancer doctors after results from a hugely successful 3 year trial were published in the medical journal The Lancet today.
The tool, called a Polygenic Risk Score (PRS), separates people into different risk groups based on their genetic sequence to predict their future risk of developing breast cancer.
Research led by Professor Elizabeth Murchison from our Cell and Molecular Biology Programme reveals new insights about the genetics of an unusual cancer that spreads between dogs.
Congratulations to Bertie Göttgens, Kathryn Lilley, Serena Nik-Zainal and Anna Philpott elected as EMBO members in recognition of their outstanding life science research.
Centre Director Prof Richard Gilbertson stars in a new Cancer Research UK TV appeal urging support for the charity to continue its life-saving work in the face of the COVID-19 pandemic.